www.t2biosystems.com
Open in
urlscan Pro
74.208.247.212
Public Scan
Submitted URL: http://www.t2biosystems.com/
Effective URL: https://www.t2biosystems.com/
Submission: On October 08 via api from US — Scanned from DE
Effective URL: https://www.t2biosystems.com/
Submission: On October 08 via api from US — Scanned from DE
Form analysis 2 forms found in the DOM
GET https://www.t2biosystems.com
<form class="elementor-search-form" role="search" action="https://www.t2biosystems.com" method="get">
<div class="elementor-search-form__toggle">
<div class="e-font-icon-svg-container"><svg aria-hidden="true" class="e-font-icon-svg e-fas-search">
<use xlink:href="#fas-search"></use>
</svg></div> <span class="elementor-screen-only">Search</span>
</div>
<div class="elementor-search-form__container">
<input placeholder="Search..." class="elementor-search-form__input" type="search" name="s" title="Search" value="">
<div class="dialog-lightbox-close-button dialog-close-button">
<svg aria-hidden="true" class="e-font-icon-svg e-eicon-close">
<use xlink:href="#eicon-close"></use>
</svg> <span class="elementor-screen-only">Close</span>
</div>
</div>
</form>GET https://www.t2biosystems.com
<form class="elementor-search-form" role="search" action="https://www.t2biosystems.com" method="get">
<div class="elementor-search-form__toggle">
<div class="e-font-icon-svg-container"><svg aria-hidden="true" class="e-font-icon-svg e-fas-search">
<use xlink:href="#fas-search"></use>
</svg></div> <span class="elementor-screen-only">Search</span>
</div>
<div class="elementor-search-form__container">
<input placeholder="Search..." class="elementor-search-form__input" type="search" name="s" title="Search" value="">
<div class="dialog-lightbox-close-button dialog-close-button">
<svg aria-hidden="true" class="e-font-icon-svg e-eicon-close">
<use xlink:href="#eicon-close"></use>
</svg> <span class="elementor-screen-only">Close</span>
</div>
</div>
</form>Text Content
Search
Close
* Products & Technology
* T2Dx Instrument
* T2Bacteria Panel
* T2Candida Panel
* T2SARS-CoV-2 Panel
* T2MR Technology
* Product Pipeline
* BARDA
* T2Resistance Panel
* T2Lyme Panel
* T2Cauris Panel
* T2Biothreat Panel
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Case Studies
* Webinars & Videos
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships
* International Distributors
* FAQ
* Media Resources
Menu
* Products & Technology
* T2Dx Instrument
* T2Bacteria Panel
* T2Candida Panel
* T2SARS-CoV-2 Panel
* T2MR Technology
* Product Pipeline
* BARDA
* T2Resistance Panel
* T2Lyme Panel
* T2Cauris Panel
* T2Biothreat Panel
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Case Studies
* Webinars & Videos
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships
* International Distributors
* FAQ
* Media Resources
* Products & Technology
* T2Bacteria Panel
* T2Candida Panel
* T2Resistance Panel
* T2Dx Instrument
* T2MR Technology
* Product Pipeline
* T2Biothreat Panel
* T2Lyme Panel
* T2Cauris Panel RUO
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Webinars & Videos
* Case Studies
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships International
* Distributors
* FAQ
* Media Resources
Menu
* Products & Technology
* T2Bacteria Panel
* T2Candida Panel
* T2Resistance Panel
* T2Dx Instrument
* T2MR Technology
* Product Pipeline
* T2Biothreat Panel
* T2Lyme Panel
* T2Cauris Panel RUO
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Webinars & Videos
* Case Studies
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships International
* Distributors
* FAQ
* Media Resources
* Investors
* Technical Support
* Contact Us
Menu
* Investors
* Technical Support
* Contact Us
* Investors
* Contact Us
Menu
* Investors
* Contact Us
Schedule a Meeting
Search
Close
* Products & Technology
* T2Dx Instrument
* T2Bacteria Panel
* T2Candida Panel
* T2SARS-CoV-2 Panel
* T2MR Technology
* Product Pipeline
* BARDA
* T2Resistance Panel
* T2Lyme Panel
* T2Cauris Panel
* T2Biothreat Panel
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Case Studies
* Webinars & Videos
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships
* International Distributors
* FAQ
* Media Resources
Menu
* Products & Technology
* T2Dx Instrument
* T2Bacteria Panel
* T2Candida Panel
* T2SARS-CoV-2 Panel
* T2MR Technology
* Product Pipeline
* BARDA
* T2Resistance Panel
* T2Lyme Panel
* T2Cauris Panel
* T2Biothreat Panel
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Case Studies
* Webinars & Videos
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships
* International Distributors
* FAQ
* Media Resources
* Products & Technology
* T2Bacteria Panel
* T2Candida Panel
* T2Resistance Panel
* T2Dx Instrument
* T2MR Technology
* Product Pipeline
* T2Biothreat Panel
* T2Lyme Panel
* T2Cauris Panel RUO
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Webinars & Videos
* Case Studies
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships International
* Distributors
* FAQ
* Media Resources
Menu
* Products & Technology
* T2Bacteria Panel
* T2Candida Panel
* T2Resistance Panel
* T2Dx Instrument
* T2MR Technology
* Product Pipeline
* T2Biothreat Panel
* T2Lyme Panel
* T2Cauris Panel RUO
* Healthcare Challenges
* Sepsis
* COVID-19
* Lyme Disease
* Resources
* Publications
* Webinars & Videos
* Case Studies
* About T2
* Our Company
* Our Mission
* News
* Leadership
* Careers
* Events
* Research Partnerships International
* Distributors
* FAQ
* Media Resources
With sepsis, every hour counts
Target therapy sooner, with species identification before the second dose of
empiric therapy
LEARN MORE
The first and only FDA-cleared diagnostic tests to provide species
identification of sepsis-causing bacterial and fungal pathogens, directly from a
whole blood sample and independent of a positive blood culture.
With sepsis, every hour counts
Target therapy sooner, with species identification before the second dose of
empiric therapy
LEARN MORE
The first and only FDA-cleared diagnostic tests to provide species
identification of sepsis-causing bacterial and fungal pathogens, directly from a
whole blood sample and independent of a positive blood culture.
T2Candida Case Study
Secondary Candidemia in Critically Ill COVID-19 Patient
READ CASE STUDY
T2Candida enabled the detection of candidemia 29 hours before a positive blood
culture was returned. Early detection allowed for the rapid initiation of
antifungal therapy in a critically ill COVID-19 patient.
T2Candida Case Study
Secondary Candidemia in Critically Ill COVID-19 Patient
READ CASE STUDY
T2Candida enabled the detection of candidemia 29 hours before a positive blood
culture was returned. Early detection allowed for the rapid initiation of
antifungal therapy in a critically ill COVID-19 patient.
ENHANCING THE STANDARD OF CARE.
* Reduce time to detection & species ID
* Target therapy sooner
* Reduce costs and length of stay
* Enhance antimicrobial stewardship
* Improve outcomes for patients
Learn More
With T2 Biosystems, hospitals can identify sepsis-causing pathogens faster and
more accurately than the standard of blood culture alone
HOSPITALS TRUST IN T2MR TECHNOLOGY
UPMC
Demonstrated 47% reduction in antifungal therapy.
Learn More
Henry Ford Health System
Realized 7 days reduction in median length of stay in the ICU.
Learn More
Lee Health
T2Bacteria positive results 20 hours sooner than blood culture.
Learn More
Huntsville Hospital
Saved ~$280 pharmacy costs per patient.
Learn More
Robert Wood Johnson Medical School
Identified escalation and de-escalation opportunities in patients tested with
T2Candida.
Learn More
Riverside Community Hospital
100% of patients who tested positive received appropriate therapy in <9 hours
Learn More
PATIENT CASE STUDIES
Real stories about the positive impact of T2 Biosystems on clinical decisions
and outcomes
SECONDARY CANDIDEMIA IN CRITICALLY ILL COVID-19 PATIENT
T2BACTERIA IDENTIFIES CAUSATIVE PATHOGEN IN A CRITICALLY ILL PATIENT WITH A
RESPIRATORY INFECTION
UTILIZING T2CANDIDA RESULT TO IMPACT APPROPRIATE THERAPY
T2BACTERIA RESULT USED TO ALTER THERAPY
NUMBERS DON'T LIE.
Sepsis is a burden on healthcare and patients, contributing to:
1 in 2-3
US hospital deaths.
11 million
deaths annually, worldwide.
$62 billion
in US healthcare costs.
Integrate T2 Biosystems panels into your hospital today!
Learn More
T2 BIOSYSTEMS OVERVIEW
T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is
dedicated to saving lives and reducing the cost of healthcare by empowering
clinicians to effectively treat patients faster than ever before. T2 Biosystems
is focused on addressing critical unmet needs in healthcare starting with
sepsis, one of the deadliest and most expensive conditions in hospitals today.
The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing
authorization from the U.S. Food and Drug Administration. All other T2
Biosystems products are considered investigational and for research use only.
T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, and T2Dx® are registered
trademarks of T2 Biosystems, Inc. “T2Biosystems” and the T2 Biosystems, Inc.
logo design are registered trademarks or trademarks of T2Biosystems, Inc. All
software and documentation is subject to T2 Biosystems, Inc. copyrights. All
rights reserved. T2Direct Diagnostics™, T2HemoStat™, T2Plex™, T2Cauris™,
T2Resistance™ and T2SARS-CoV-2™ are trademarks of T2 Biosystems, Inc.
© 2022 T2 Biosystems, Inc.
JOIN IN ON TWITTER
T2 Biosystems
@T2Bio
Visit us at booth 114 during #IDWeek2022 for live demos of the T2Dx Instrument!
#IDSA #SHEA #SIDP
* October 5, 2022
T2 Biosystems
@T2Bio
Stop by booth 124 during the #CAP22 meeting to learn more about species
identification direct from a whole blood sample! @Pathologists #Pathologists
#Lab #Laboratory #CAP
* October 4, 2022
SITEMAP
* T2MR Technology
* T2Bacteria Panel
* T2Candida Panel
* Product Pipeline
* T2Dx Instrument
* Terms of Use & Privacy Policy
* Standard Terms & Conditions
Menu
* T2MR Technology
* T2Bacteria Panel
* T2Candida Panel
* Product Pipeline
* T2Dx Instrument
* Terms of Use & Privacy Policy
* Standard Terms & Conditions
FOLLOW US ON SOCIAL
Linkedin-in Twitter
* About T2
* Investors
* Technical Support
* Careers
* Contact Us
* Conflict Minerals Report
* T2 Compliance Program
* Declaration of Compliance
Menu
* About T2
* Investors
* Technical Support
* Careers
* Contact Us
* Conflict Minerals Report
* T2 Compliance Program
* Declaration of Compliance
Please tell us where you are visiting from: United States | Outside the United
States